Use of Osimertinib in 2nd Line Setting in Uncommon and Compound EGFR Mutations in NSCLC Patients: A Descriptive Study in Alberta, Canada
Osimertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Use of Osimertinib in 2nd Line Setting in Uncommon and Compound EGFR Mutations in NSCLC Patients: A Descriptive Study in Alberta, Canada ### Output: Osimertinib